Medically reviewed by Danielle Weiss, MD Diabetic macular edema (DME) is a leading cause of vision loss in people with ...

Diabetic macular edema remains a significant cause of vision loss in individuals with diabetes, often requiring invasive ...

While macular degeneration is a disease of the macula, a part of the retina at the back of the eye responsible for central vision, cataracts are cloudy areas that develop in the lens of one or ...

Unity Biotechnology has reported outcomes from its randomised Phase IIb ASPIRE study of intravitreal UBX1325 for diabetic ...

UBX1325 is a novel BCL-xL inhibitor designed to eliminate senescent cells in diabetic retinal blood vessels, while leaving ...

As India is dubbed the diabetic capital of the world, there is a growing concern that diabetic retinopathy (DR), an eye ...

The investigators conducted a prospective interventional study to determine the therapeutic anatomic and functional effects ...

Treatment with UBX1325 resulted in vision gains comparable to aflibercept at weeks 24 and 36 in difficult-to-treat patient populationUBX1325 was ...